# Dr. C. Vivek Lal

> Dr. C. Vivek Lal is a physician-scientist, founder and CEO of resbiotic, and founder of Biostack Ventures. Raised in the Andaman Islands and trained in India and the United States, he combines academic work at UAB with company building and investment. His ventures include Alveolus Bio and Urgent Care for Children, which Zarminali acquired in June 2025.

- **Role:** Founder & CEO at resbiotic
- **Organizations:** resbiotic, Biostack Ventures, Alveolus Bio, University of Alabama at Birmingham, Urgent Care for Children (co-founder; acquired in 2025), BIO Alabama (documented executive board service), Microbiome Therapeutics Innovation Group (documented board service)
- **Education:** Medical education, Government Medical College, Nagpur, Residency training, University of South Alabama, Clinical fellowship and research fellowship, UT Southwestern Medical Center, Doctoral training listed under Genetics, Genomics and Bioinformatics Theme, University of Alabama at Birmingham, Executive program in drug and device development, Massachusetts Institute of Technology
- **Known for:** 2023 UAB Harbert Institute Award for Excellence in Entrepreneurship, 2024 membership in UAB’s campus chapter of the National Academy of Inventors, Founded resbiotic, winner of UAB’s 2022 Start-Up of the Year award and the 2026 NutraIngredients USA Start-Up Award

## Career timeline

- **2020** — Founded ResBiotic, as reported in contemporaneous April 2021 coverage.
- **2021** — ResBiotic announced $3 million in seed funding; Lal was identified as founder and chief scientific officer.
- **2022** — First resbiotic product launched in January, according to his later interview; resbiotic received UAB Start-Up of the Year recognition.
- **2023** — Received UAB Harbert Institute Award for Excellence in Entrepreneurship.
- **2024** — Joined UAB campus chapter of the National Academy of Inventors.
- **2025** — Urgent Care for Children was acquired by Zarminali in June; resbiotic announced $14.5 million total funding including an $8 million Series A in September.
- **2026** — Resbiotic expanded into Walgreens and Walmart in May, launched at H-E-B in July, and won the NutraIngredients USA Start-Up Award.

## Achievements

- 2023 UAB Harbert Institute Award for Excellence in Entrepreneurship
- 2024 membership in UAB’s campus chapter of the National Academy of Inventors
- Founded resbiotic, winner of UAB’s 2022 Start-Up of the Year award and the 2026 NutraIngredients USA Start-Up Award
- Co-founded Urgent Care for Children, acquired by Zarminali in June 2025
- Conference biography credits more than 100 research manuscripts or abstracts; this is not a count of peer-reviewed articles alone.

## Latest updates

- **2026-08** — NutraIngredients published Lal’s reflections following resbiotic’s 2026 Start-Up Award win.
- **2026-07** — Resbiotic announced its H-E-B launch across Texas on July 31 and described the company as Dallas-headquartered.
- **2026-05** — Resbiotic announced expansion at Walgreens and Walmart on May 5.
- **2025-09** — Resbiotic announced $14.5 million in total funding, including a recently concluded $8 million Series A.
- **2025-06** — Zarminali announced acquisition of Urgent Care for Children on June 30.

## Links

- Website: https://www.biostackventures.com/
- LinkedIn: https://www.linkedin.com/in/c-vivek-lal-md-faap-20183913
- Instagram: https://www.instagram.com/dr.viveklal/
- Facebook: https://www.facebook.com/lalbullet

---

Profile page: https://yespress.io/c-vivek-lal
Published by YesPress — https://yespress.io
Last updated: 2026-10-14